by
Colby Coates, Editor in Chief | December 11, 2007
To date, more than
100 of Accuray's
CyberKnife Systems have
been installed at
hospitals around
the world.
Accuray Inc., a Sunnyvale, CA company specializing in the field of radiosurgery, and the University of Texas M.D. Anderson Cancer Center, Houston, TX, have teamed up to launch a worldwide study comparing the pros and cons of regular surgery versus CyberKnife surgery for lung cancer patients.
As the medical community moves toward more minimally invasive alternatives to treatment, data that compare outcomes of surgery to less invasive options becomes extremely important. Thus far, results of the two different surgical techniques appear comparable.
Sites from around the world will participate in the proposed 1,200 patient study with coordination and oversight by M.D. Anderson. Doctors hope to determine the most accurate method of treatment that will maximize radiation to the tumor while minimizing damage to surrounding tissue. To date, more than 100 of Accuray's CyberKnife Systems have been installed at hospitals around the world.
Ad Statistics
Times Displayed: 1015
Times Visited: 6 Keep biomedical devices ready to go, so care teams can be ready to care for patients. GE HealthCare’s ReadySee™ helps overcome frustrations due to lack of network and device visibility, manual troubleshooting, and downtime.
